| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 20.01▼ | 20.14▼ |
| MA10 | N/A | N/A | N/A | 20.10▼ | 20.16▼ |
| MA20 | N/A | N/A | N/A | 20.22▼ | N/A |
| MA50 | N/A | N/A | N/A | 20.16▼ | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | -0.042▼ | N/A |
| RSI | N/A | N/A | N/A | 38.450▼ | N/A |
| STOCH | N/A | N/A | N/A | 11.293▼ | N/A |
| WILL %R | N/A | N/A | N/A | -81.443▼ | -81.443▼ |
| CCI | N/A | N/A | N/A | -98.443 | -118.868▼ |
|
Wednesday, March 11, 2026 01:56 PM
CRISPR Therapeutics (NASDAQ:CRSP) is one of the best stocks for 20 years. On February 12, CRISPR Therapeutics announced its financial results for 2025, highlighting a period of significant commercial ...
|
|
Wednesday, March 11, 2026 04:30 AM
CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount of its convertible senior notes due 2031 (the “notes”) in a private ...
|
|
Tuesday, March 10, 2026 05:46 AM
CRISPR Therapeutics AG (NASDAQ:CRSP) shares declined 6.75% on Tuesday after the company revealed plans to raise $350 million through a convertible senior notes offering. The gene-editing firm said it ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/03/26 | 19.9901 | 19.995 | 19.9901 | 19.995 | 108 |
| 13/03/26 | 19.905 | 19.905 | 19.905 | 19.905 | 3 |
| 12/03/26 | 19.97 | 19.97 | 19.97 | 19.97 | 12 |
| 11/03/26 | 20.0486 | 20.0486 | 20.0486 | 20.0486 | 8 |
| 10/03/26 | 20.165 | 20.165 | 20.14 | 20.14 | 49,542 |
| 09/03/26 | 20.17 | 20.2056 | 20.17 | 20.2056 | 198,839 |
| 06/03/26 | 20.117 | 20.117 | 20.117 | 20.117 | 2 |
| 05/03/26 | 20.17 | 20.17 | 20.17 | 20.17 | 100 |
| 04/03/26 | 20.2398 | 20.2398 | 20.2398 | 20.2398 | 4 |
| 03/03/26 | 20.235 | 20.235 | 20.235 | 20.235 | 100 |
|
|
||||
|
|
||||
|
|